✦ LIBER ✦

Adjuvant trastuzumab use in high-risk breast cancer patients may prevent development of contralateral estrogen receptor-negative breast tumors

✍ Scribed by Kadri Altundag; Ozden Altundag; Rabiul Islam; Ozlem Gundeslioglu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High recurrence risk and use of adjuvant

✍ Akiyo Horio; Takashi Fujita; Hironori Hayashi; Masaya Hattori; Naoto Kondou; Mai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 505 KB

Risk estimation of distant metastasis in

✍ Andrew Tutt; Alice Wang; Charles Rowland; Cheryl Gillett; Kit Lau; Karen Chew; H 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 377 KB

A randomized phase III trial of adjuvant

✍ J. Andersen; M. Andersson; K.W. Andersen; P. Dombemowsky; H.T. Mouridsen; C. Ros 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Detection of disseminated tumor cells in

✍ Chidananda M. Siddappa, Mark A. Watson, Sreeraj G. Pillai, Kathryn Trinkaus, Tim 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 610 KB